(Q42950762)

11 November 2017

title

Oral ulcer associated with alendronate: a case report (English)

1 reference

11 November 2017

4

Gunnar Warfvinge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20674418

14 June 2024

author name string

Mohammad Kharazmi

series ordinal

1

1 reference

11 November 2017

Kerstin Sjöqvist

series ordinal

2

1 reference

11 November 2017

Milad Rizk

series ordinal

3

1 reference

11 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20674418

14 June 2024

publication date

31 July 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S107921041000288X?httpAccept=text/xml

1 reference

10.1016/J.TRIPLEO.2010.04.035

DOI

https://api.crossref.org/works/10.1016/J.TRIPLEO.2010.04.035

https://api.elsevier.com/content/article/PII:S107921041000288X?httpAccept=text/plain

14 June 2024

1 reference

10.1016/J.TRIPLEO.2010.04.035

DOI

https://api.crossref.org/works/10.1016/J.TRIPLEO.2010.04.035

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

14 June 2024

published in

1 reference

11 November 2017

volume

110

1 reference

11 November 2017

issue

6

1 reference

11 November 2017

page(s)

e11-3

1 reference

Esophagitis associated with the use of alendronate

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Severe oral ulcerations induced by alendronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Chronic erosive and ulcerative oral lesions caused by incorrect administration of alendronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Alendronate and mouth ulcers: careful interrogation of the patient to start with

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Images in clinical medicine. Bisphosphonate-associated contact stomatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Chronic mouth ulcer due to inadequate ingestion of alendronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Oral mucosal irritation with incorrect use of alendronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Mouth sores caused by alendronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Alendronate induces gastric injury and delays ulcer healing in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

New Insights Into the Molecular Mechanisms of Action of Bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Nonclinical model for assessing gastric effects of bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

Clinical concerns of alendronate use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2010.04.035

10.1016/J.TRIPLEO.2010.04.035

7 January 2021

Identifiers

DOI

1 reference

11 November 2017

1 reference